Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 2:15 PM
Xilio Therapeutics Revenue
Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending March 31, 2025, Xilio Therapeutics generated $2.93M in revenue.
Revenue (ttm)
6.34M
Revenue Growth
n/a
Price / Sales Ratio
8.06
Revenue / Employee
99.13K
Employees
64
Market Cap
36.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|